Aubagio (Genzyme Corp.)
Welcome to the PulseAid listing for the Aubagio drug offered from Genzyme Corp.. This Pyrimidine Synthesis Inhibitor [EPC],Dihydroorotate Dehydrogenase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genzyme Corp. |
| NON-PROPRIETARY NAME: | teriflunomide |
| SUBSTANCE NAME: | TERIFLUNOMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Pyrimidine Synthesis Inhibitor [EPC],Dihydroorotate Dehydrogenase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-05-01 |
| END MARKETING DATE: | 2054-12-31 |
Aubagio HUMAN PRESCRIPTION DRUG Details:
| Item Description | Aubagio from Genzyme Corp. |
| LABELER NAME: | Genzyme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 14(mg/1) |
| START MARKETING DATE: | 2013-05-01 |
| END MARKETING DATE: | 2054-12-31 |
| PRODUCT ID: | 58468-0210_7c6d1678-6f96-4b89-b130-2616db908d68 |
| PRODUCT NDC: | 58468-0210 |
| APPLICATION NUMBER: | NDA202992 |
Other TERIFLUNOMIDE Pharmaceutical Manufacturers / Labelers:
